Hyloris Pharmaceuticals SA (EBR: HYL)
Belgium
· Delayed Price · Currency is EUR 5.60
-0.16 (-2.78%)
Jan 17, 2025, 3:58 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €162.40 million as of January 21, 2025. Its market cap has decreased by -55.56% in one year.
Market Cap
162.40M
Enterprise Value
136.33M
Revenue
6.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.60
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 162.40M, a decrease of -33.63%. That is a compound annual growth rate of -8.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 162.40M | -11.31% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 38.50B |
| UCB SA | 34.62B |
| Financière de Tubize | 6.37B |
| Fagron NV | 1.25B |
| Nyxoah | 388.85M |
| Ion Beam Applications | 371.77M |
| Onward Medical | 269.56M |
| Sequana Medical NV | 113.76M |